Steve Dubin, Chief Executive Officer at MARTEK BIOSCIENCES CORP (MATK), bought 1,000 shares at $28.15 ($28K) on 2007-12-18, disclosed to the SEC on 2007-12-18.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| Filing → |
| MATK | BUY | 2007-03-30 | $51K | — | Filing → |
| MATK | BUY | 2006-09-11 | $83K | — | Filing → |